SPONSOR
Anhui Provincial Hospital
Total Trials
3
Recruiting
3
Phases
Phase 4, Phase 1, Phase 2
Conditions studied: Hepatocellular Carcinoma (HCC)Liver DiseasesSmall-cell Lung CancerEsophageal Squamous Cell Carcinoma
Anhui Provincial Hospital is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Hepatocellular Carcinoma (HCC), Liver Diseases, Small-cell Lung Cancer, Esophageal Squamous Cell Carcinoma.
The trial portfolio spans Phase 4, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Anhui Provincial Hospital
How many clinical trials has Anhui Provincial Hospital sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Anhui Provincial Hospital, of which 3 are actively recruiting participants. These trials cover conditions including Hepatocellular Carcinoma (HCC), Liver Diseases, Small-cell Lung Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Anhui Provincial Hospital research focus on?
Anhui Provincial Hospital clinical trials span Hepatocellular Carcinoma (HCC), Liver Diseases, Small-cell Lung Cancer, Esophageal Squamous Cell Carcinoma. The research pipeline includes Phase 4, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Anhui Provincial Hospital clinical trial?
To participate in a Anhui Provincial Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Anhui Provincial Hospital trials with current recruitment status updated daily.
Clinical Trials by Anhui Provincial Hospital
NCT07150624 Phase 4
Recruiting
The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine
Hepatocellular Carcinoma (HCC)
NCT06527898 Phase 1, Phase 2
Recruiting
Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer
Small-cell Lung Cancer
NCT06408584
Recruiting
Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab
Esophageal Squamous Cell Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology